Select Equity Group, L.P. Maravai Lifesciences Holdings, Inc. Transaction History

Select Equity Group, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $174 Million - $345 Million	-13,926,045 Reduced 84.65%	2,524,793 $36.1 Million
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $54.9 Million - $80.9 Million	-2,664,088 Reduced 13.94%	16,450,838 $420 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $387,363 - $557,327	14,870 Added 0.08%	19,114,926 $543 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $35.3 Million - $59 Million	-1,442,447 Reduced 7.02%	19,100,056 $674 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $295 Million - $387 Million	8,420,492 Added 69.46%	20,542,503 $861 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $157 Million - $259 Million	4,277,119 Added 54.52%	12,122,011 $595 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $105 Million - $146 Million	3,242,543 Added 70.45%	7,844,892 $327 Million
Q1 2021 May 17, 2021	BUY	$25.8 - $38.49 $103 Million - $154 Million	3,993,858 Added 656.35%	4,602,349 $164 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $14.9 Million - $18.8 Million	608,491 New	608,491 $17.1 Million

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $627M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Select Equity Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Select Equity Group, L.P. with notifications on news.